Results 41 to 50 of about 3,825 (160)

Case Report: Kawasaki disease associated with acute generalized exanthematous pustulosis secondary to carbocysteine

open access: yesFrontiers in Pediatrics
Acute generalized exanthematous pustulosis (AGEP) is an uncommon eruption characterized by sterile pustules on an erythematous background, which is usually associated with drugs. AGEP is described as a self-limiting disease with favorable prognosis.
Takashi Furuta   +5 more
doaj   +1 more source

Toxic epidermal necrolysis, DRESS, AGEP: Do overlap cases exist? [PDF]

open access: yes, 2012
Background Severe cutaneous adverse reactions to drugs (SCARs) include acute generalized exanthematous pustulosis (AGEP), drug reaction with eosinophilia and systemic symptoms (DRESS) and epidermal necrolysis (Stevens-Johnson syndrome–toxic epidermal ...
Ortonne, Nicolas   +24 more
core   +2 more sources

Updated EAACI Statement on Drug Hypersensitivity Skin Testing: Methodology and Non‐Irritative Concentrations

open access: yesAllergy, EarlyView.
ABSTRACT These updated EAACI guidelines aim to standardize skin testing methodologies for both immediate and non‐immediate drug hypersensitivity reactions. For immediate reactions, the optimal testing window is 4–6 weeks post‐reaction; whereas beyond 6 months, false‐negative results increase.
Annick Barbaud   +14 more
wiley   +1 more source

Nomenclature on Immune‐Mediated Drug Reactions: An EAACI Position Paper

open access: yesAllergy, EarlyView.
ABSTRACT Over the past several decades, there have been significant advances in our understanding of both immunological and pharmacological mechanisms of adverse drug reactions (ADRs). Immune‐mediated drug reactions (IMDRs) represent a small proportion of ADRs and are caused by a pathological activation of the immune system or inflammatory pathways ...
Maria J. Torres   +19 more
wiley   +1 more source

AGEP Student survey [PDF]

open access: yes, 2013
AGEP alumni from ISU, UoI, UNI were survey in 2012 as part of the closeout activities of the NSF AGEP grant. Here is a summary.
Ogilvie, Craig
core  

A Delayed Presentation of Acute Generalized Exanthematous Pustulosis (AGEP)

open access: yes, 2015
Acute Generalized Exanthematous Pustulosis (AGEP) is a Type IVd hypersensitivity reaction that usually occurs within 1-5 days of drug exposure. The diagnosis is clinical and confirmed by skin biopsy.
Fernandez J   +2 more
core   +1 more source

Adolescent Girls Empowerment Program (AGEP): Health [PDF]

open access: yes, 2018
The Adolescent Girls Empowerment Program (AGEP) intervention was conducted over two years to support more than 11,000 vulnerable adolescent girls in Zambia.
Soler-Hampejsek, Erica   +3 more
core   +1 more source

Cephalexin-induced acute generalized exanthematous pustulosis

open access: yesDermatology Reports, 2018
Cephalexin is a cephalosporin antibiotic that is commonly used in the treatment of infectious diseases. We report a patient exhibiting a rare adverse effect of cephalexin: drug-induced Acute Generalized Exanthematous Pustulosis (AGEP).
Matthew DaCunha   +2 more
doaj   +1 more source

Dermatologic Toxicities Associated With Novel Pan‐RAS/RAF Inhibitors

open access: yesJournal of Cutaneous Pathology, EarlyView.
ABSTRACT Background The mitogen‐activated protein kinase (MAPK) pathway plays a key role in cell‐cycle regulation and tumor progression in cancer. Dermatologic toxicities (DTs) to newer pan‐RAS (RMC‐6236) and pan‐RAF (LXH254/naporafenib) inhibitors are emerging.
Lin J. He   +11 more
wiley   +1 more source

Ceftriaxone induced acute generalized exanthematous pustulosis confirmed with patch test

open access: yesTrends in Pediatrics, 2023
Background: Acute generalized exanthematous pustulosis (AGEP) is a rare cutaneous drug reaction presenting with rapid-onset sterile pustules on edematous erythema.
Özge Türkyılmaz Uçar   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy